Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Dec 27, 2020; 12(12): 507-519
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.507
Published online Dec 27, 2020. doi: 10.4240/wjgs.v12.i12.507
Table 1 Patient characteristics in the compared groups
Overall (n = 148) | SOO (+) (n = 25) | SOO (-) (n = 123) | P value | |
Age1 (yr), (range) | 48 (13-84) | 50 (13-77) | 48 (14-84) | 0.614 |
Gender | ||||
Male | 95 (64.2%) | 18 (72.0%) | 77 (62.6%) | 0.372 |
Female | 53 (35.8%) | 7 (28.0%) | 46 (37.4%) | |
Indication for surgery | ||||
Medical intractability | 118 (79.7%) | 16 (64.0%) | 102 (82.9%) | 0.032 |
Malignancy or dysplasia | 30 (20.3%) | 9 (36.0%) | 21 (17.1%) | |
BMI1 (kg/m2), (range) | 20.1 (11.7-36.1) | 19.8 (14.8-25.5) | 20.3 (11.7-36.1) | 0.634 |
Mayo endoscopic score1 (range) | 3 (0-3) | 2 (0-3) | 3 (0-3) | 0.186 |
Extent of disease | ||||
Pancolitis | 137 (92.6%) | 24 (96.0%) | 113 (91.9%) | 0.691 |
Left-sided colitis | 11 (7.4%) | 1 (4.0%) | 10 (8.1%) | |
Proctitis | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | |
Disease duration1, (mo), (range) | 33 (0-413) | 40.5 (3-336) | 33 (0-413) | 0.535 |
Disease severity | ||||
Mild | 25 (16.9%) | 6 (24.0%) | 19 (15.4%) | 0.341 |
Moderate | 71 (48.0%) | 14 (56.0%) | 57 (46.3%) | |
Severe | 38 (25.7%) | 4 (16.0%) | 34 (27.6%) | |
Fulminant | 14 (9.5%) | 1 (4.0%) | 13 (10.6%) | |
Total glucocorticoid dose from onset of UC to surgery2 | ||||
10000 mg or more | 9 (7.3%) | 2 (10.0%) | 7 (6.7%) | 0.637 |
Less than 10000 mg | 115 (92.7%) | 18 (90.0%) | 97 (93.3%) | |
Total glucocorticoid dose 1 mo before surgery1 (mg), (range) | 0 (0-1720) | 0 (0-765) | 0 (0-1720) | 0.026 |
Preoperative total protein level1 (g/dL), (range) | 6.4 (2.5-9.3) | 6.8 (4.5-9.3) | 6.3 (2.5-8.6) | 0.048 |
Preoperative albumin level1 (g/dL), (range) | 3.2 (1.4-4.9) | 3.6 (2.0-4.6) | 3.1 (1.4-4.9) | 0.203 |
Preoperative white blood cell count1 (cells/μL), (range) | 7455 (1850-20080) | 7500 (2660-16670) | 7450 (1850-20080) | 0.543 |
Preoperative C-reactive protein level1 (mg/dL), (range) | 1.4 (0.0-32.4) | 1.1 (0.0-8.8) | 1.57 (0.0-32.4) | 0.335 |
Onodera Prognostic Nutritional index1 (range) | 37.8 (15.9-57.5) | 39.3 (29.2-56.9) | 37.6 (15.9-57.5) | 0.274 |
Table 2 Operative details and outcomes and computed tomography measurements in the compared groups
Overall (n = 148) | SOO (+) (n = 25) | SOO (-) (n = 123) | P value | |
Surgical approach | ||||
Laparoscopy | 146 (98.6%) | 25 (100.0%) | 121 (98.4%) | 1.000 |
Open | 2 (1.4%) | 0 (0.0%) | 2 (1.6%) | |
Site of stoma | ||||
Right | 85 (57.4%) | 10 (40.0%) | 75 (61.0%) | 0.053 |
Left | 63 (42.6%) | 15 (60.0%) | 48 (39.0%) | |
Type of stoma | ||||
End | 58 (39.2%) | 3 (12.0%) | 55 (44.7%) | 0.002 |
Loop | 90 (60.8%) | 22 (88.0%) | 68 (55.3%) | |
Operative time1 (min), (range) | 346 (208-631) | 339 (234-595) | 347 (208-631) | 0.890 |
Intraoperative bleeding1 (mL), (range) | 73.5 (4-1316) | 51 (5-811) | 80 (4-1316) | 0.310 |
Maximum stoma drainage volume1 (mL), (range) | 1800 (150-7800) | 2300 (450-5230) | 1690 (150-7800) | 0.004 |
Days from surgery to maximum stoma drainage volume1 (d), (range) | 6 (1-22) | 8 (2-21) | 4 (1-22) | 0.326 |
Adhesions below the ileostomy2 | ||||
Yes | 21 (22.8%) | 7 (35.0%) | 14 (19.4%) | 0.123 |
None | 71 (77.2%) | 13 (65.0%) | 58 (80.6%) | |
Rectus abdominal muscle thickness at umbilical level1 (mm), (range) | 9.6 (3.6-15.7) | 10.4 (6.1-14.2) | 9.6 (3.6-15.7) | 0.189 |
Subcutaneous fat thickness at umbilical level1 (mm), (range) | 15.5 (2.4-52.3) | 11.6 (6.6-36.0) | 16.3 (2.4-52.3) | 0.051 |
Table 3 Multivariate analysis of risk factors associated with stoma outlet obstruction
Factor | Odds ratio | 95%CI | P value | |
Lower | Upper | |||
Malignancy or dysplasia | 0.558 | 0.156 | 1.991 | 0.369 |
Total glucocorticoid dose 1 mo before surgery | 0.998 | 0.995 | 1.001 | 0.244 |
Preoperative total protein level | 1.220 | 0.686 | 2.168 | 0.499 |
Loop ileostomy | 7.315 | 1.514 | 35.332 | 0.013 |
Maximum stoma drainage volume | 1.000 | 1.000 | 1.001 | 0.035 |
Table 4 Patients characteristics in relation to stoma sidedness with ileal pouch-anal anastomosis
Overall (n = 90) | Right side (n = 31) | Left side (n = 59) | P value | |
Age1 (yr), (range) | 41 (13-71) | 41 (14-71) | 41 (13-67) | 0.690 |
Gender | ||||
Male | 54 (60.0%) | 17 (54.8%) | 37 (62.7%) | 0.469 |
Female | 36 (40.0%) | 14 (45.2%) | 22 (37.3%) | |
Indication for surgery | ||||
Medical intractability | 72 (80.0%) | 26 (83.9%) | 46 (78.0%) | 0.506 |
Malignancy or dysplasia | 18 (20.0%) | 5 (16.1%) | 13 (22.0%) | |
BMI1 (kg/m2), (range) | 19.8 (13.9-36.1) | 21.8 (16.0-27.8) | 19.3 (13.9-36.1) | 0.023 |
Mayo endoscopic score1 (range) | 3 (0-3) | 3 (0-3) | 3 (0-3) | 0.878 |
Extent of disease | ||||
Pancolitis | 84 (93.3%) | 29 (93.5%) | 55 (93.2%) | 0.662 |
Left-sided colitis | 6 (6.7%) | 2 (6.5%) | 4 (6.8%) | |
Proctitis | 0 | 0 | 0 | |
Disease duration1 (mo), (range) | 38 (1-336) | 21 (1-252) | 56 (1-336) | 0.016 |
Disease severity | ||||
Mild | 17 (18.9%) | 6 (19.4%) | 11 (18.6%) | 0.471 |
Moderate | 44 (48.9%) | 12 (38.7%) | 32 (54.2%) | |
Severe | 21 (23.3%) | 9 (29.0%) | 12 (20.3%) | |
Fulminant | 8 (8.9%) | 4 (12.9%) | 4 (6.8%) | |
Total glucocorticoid dose from onset of UC to surgery2 | ||||
10000 mg or more | 7 (9.3%) | 2 (8.7%) | 5 (9.4%) | 0.644 |
Less than 10000 mg | 69 (90.7%) | 21 (91.3%) | 48 (90.6%) | |
Total glucocorticoid dose 1 mo before surgery1 (mg), (range) | 0 (0-1000) | 0 (0-595) | 0 (0-1000) | 0.955 |
Preoperative total protein level1 (g/dL), (range) | 6.45 (4.2-9.3) | 6.4 (4.2-8.5) | 6.45 (4.2-9.3) | 0.919 |
Preoperative albumin level1 (g/dL), (range) | 3.45 (1.8-4.9) | 3.6 (2.1-4.8) | 3.4 (1.8-4.9) | 0.586 |
Preoperative white blood cell count1 (cells/μL), (range) | 7315 (2660-20080) | 6120 (2660-10630) | 8770 (2850-20080) | < 0.001 |
Preoperative C-reactive protein level1 (mg/dL), (range) | 0.78 (0.01-17.41) | 0.48 (0.01-8.78) | 1.06 (0.02-17.41) | 0.155 |
Onodera Prognostic Nutritional index1 (range) | 41.4 (22.2-57.5) | 39.6 (24.7-57.5) | 42.0 (22.2-57.5) | 0.977 |
Table 5 Operative details and outcomes and computed tomography measurements in relation to stoma sidedness with ileal pouch-anal anastomosis
Overall (n = 90) | Right side (n = 31) | Left side (n = 59) | P value | |
Surgical approach | ||||
Laparoscopy | 89 (98.9%) | 30 (96.8%) | 59 (100%) | 0.344 |
Open | 1 (1.1%) | 1 (3.2%) | 0 | |
Operative time1 (min), (range) | 346 (222-631) | 347 (227-487) | 339 (222-631) | 0.393 |
Intraoperative bleeding1 (mL), (range) | 61.5 (5-741) | 52 (5-337) | 63 (5-741) | 0.959 |
Maximum stoma drainage volume1 (mL), (range) | 2000 (150-5230) | 1900 (150-4600) | 2000 (400-5230) | 0.577 |
Days from surgery to maximum stoma drainage volume1 (d), (range) | 6 (1-21) | 6 (1-21) | 6 (1-14) | 0.051 |
Rectus abdominal muscle thickness at umbilical level1 (mm), (range) | 9.8 (5.7-15.7) | 10.65 (6.3-13.6) | 9.5 (5.7-15.7) | 0.228 |
Subcutaneous fat thickness at umbilical level1 (mm), (range) | 15.7 (2.9-52.3) | 16.9 (7.2-42.5) | 13.8 (2.9-52.3) | 0.058 |
Stoma outlet obstruction | ||||
Yes | 22 (24.4%) | 8 (25.8%) | 14 (23.7%) | 0.827 |
None | 68 (75.6%) | 23 (74.2%) | 45 (76.3%) | |
Distance from pouch to stoma (cm), (range) | 30 (30-50) | 30 (30-50) | 40 (30-50) | < 0.001 |
IPAA dehiscence | ||||
Yes | 6 (6.7%) | 0 | 6 (10.2%) | 0.072 |
None | 84 (93.3%) | 31 (100%) | 53 (89.8%) | |
Postoperative complications (Clavien-Dindo classification) | ||||
Grade 1 or less | 47 (52.2%) | 15 (48.4%) | 32 (54.2%) | 0.598 |
Grade 2 or higher | 43 (47.8%) | 16 (51.6%) | 27 (45.8%) |
Table 6 Patient characteristics in the stoma outlet obstruction group
sSOO (n = 18) | rSOO (n = 7) | P value | |
Age1 (yr), (range) | 50.5 (13-77) | 50 (16-71) | 0.745 |
Gender | |||
Male | 6 (33.3%) | 6 (85.7%) | 0.337 |
Female | 12 (66.7%) | 1 (14.3%) | |
Indication for surgery | |||
Medical intractability | 12 (66.7%) | 4 (57.1%) | 0.499 |
Malignancy or dysplasia | 6 (33.3%) | 3 (42.9%) | |
BMI1 (kg/m2), (range) | 18.9 (14.8-25.5) | 21.8 (19.0-24.2) | 0.158 |
Mayo endoscopic score1 (range) | 2 (0-3) | 2 (0-3) | 0.657 |
Extent of disease | |||
Pancolitis | 17 (94.4%) | 7 (100.0%) | 0.720 |
Left-sided colitis | 1 (5.6%) | 0 (0.0%) | |
Proctitis | 0 (0.0%) | 0 (0.0%) | |
Disease duration1 (mo), (range) | 40.5 (3-336) | 49 (15-108) | 0.923 |
Disease severity | |||
Mild | 5 (27.8%) | 1 (14.3%) | 0.141 |
Moderate | 11 (61.1%) | 3 (42.9%) | |
Severe | 1 (5.6%) | 3 (42.9%) | |
Fulminant | 1 (5.6%) | 0 (0.0%) | |
Total glucocorticoid dose from onset of UC to surgery2 | |||
10000 mg or more | 1 | 1 | 0.521 |
Less than 10000 mg | 13 | 5 | |
Total glucocorticoid dose 1 mo before surgery1 (mg), (range) | 0 (0-765) | 0 (0-280) | 0.745 |
Preoperative total protein level1 (g/dL), (range) | 6.8 (4.8-9.3) | 6.8 (4.5-8.1) | 0.745 |
Preoperative albumin level1 (g/dL), (range) | 3.5 (2.0-4.6) | 4.2 (2.3-4.6) | 0.657 |
Table 7 Operative details and outcomes and computed tomography measurements in the stoma outlet obstruction group
sSOO (n = 18) | rSOO (n = 7) | P value | |
Surgical approach | |||
Laparoscopy | 18 (100.0%) | 7 (100.0%) | |
Open | 0 (0.0%) | 0 (0.0%) | |
Site of stoma | |||
Right | 6 (33.3%) | 4 (57.1%) | 0.261 |
Left | 12 (66.7%) | 3 (42.9%) | |
Type of stoma | |||
End | 3 (16.7%) | 0 (0.0%) | 0.355 |
Loop | 15 (83.3%) | 7 (100.0%) | |
Operative time1 (min), (range) | 333 (234-595) | 345 (258-441) | 0.929 |
Intraoperative bleeding1 (mL), (range) | 56.5 (5-811) | 51 (20-78) | 0.495 |
Maximum stoma drainage volume1 (mL), (range) | 2250 (450-5230) | 2660 (800-4600) | 0.492 |
Rectus abdominal muscle thickness at umbilical level1 (mm), (range) | 9.3 (6.1-13.3) | 12.7 (8.9-14.2) | 0.006 |
Subcutaneous fat thickness at umbilical level1 (mm), (range) | 11.5 (6.6-36.0) | 11.6 (7.3-20.4) | 0.836 |
Table 8 Multivariate analysis of the risk factors for repeated stoma outlet obstruction
Factor | Odds ratio | 95%CI | P value | |
Lower | Upper | |||
Rectus abdominal muscle thickness at umbilical level | 2.249 | 1.176 | 4.300 | 0.014 |
- Citation: Kitahara T, Sato Y, Oshiro T, Matsunaga R, Nagashima M, Okazumi S. Risk factors for postoperative stoma outlet obstruction in ulcerative colitis. World J Gastrointest Surg 2020; 12(12): 507-519
- URL: https://www.wjgnet.com/1948-9366/full/v12/i12/507.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i12.507